National Cancer Center Japan and Mitsui Fudosan Agree on
Accommodation Facility at
the National Cancer Center Hospital East in Kashiwa-no-ha Smart City
- Support for Cancer Treatment and Research , Open in 2022 -
June 22, 2020
National Cancer Center Japan
Mitsui Fudosan Co., Ltd.
- An accommodation facility will be constructed on the premises of the National Cancer Center Hospital East, to accommodate cancer patients and family, and researchers from all over Japan and abroad.
- A private-public-academia partnership between the National Cancer Center Hospital East and Mitsui Fudosan, the two partners will create a new clinical model utilizing 5G, IT and other technologies in the Kashiwa-no-ha area of Chiba Prefecture.
Tokyo, Japan, June 22, 2020 - Mitsui Fudosan Co., Ltd., a leading global real estate company headquartered in Tokyo, and National Cancer Center Japan (Headquarters: Chuo-ku, Tokyo; President: Hitoshi Nakagama: hereinafter “NCC”) concluded a fixed-term land lease contract for commercial use on May 27. Under this contract, NCC will lease a part of the grounds of the National Cancer Center Hospital East (Location: 6-5-1 Kashiwa-no-ha, Kashiwa City, Chiba Prefecture; Director: Atsushi Ohtsu, M.D., Ph.D.; hereinafter “NCC Hospital East”) to Mitsui Fudosan, to develop an accommodation facility for the convenience of cancer patients and their accompanying family members and creating a new clinical model in the Kashiwa-no-ha area of Chiba Prefecture.
■ A hospital-linked accommodation facility supporting regular outpatient treatments and hospitalization for many patients and assist their family members
NCC Hospital East, one of the leading specialized cancer hospitals in Japan, treats nearly 300,000 cancer patients a year from not only the Kashiwa-no-ha area and surrounding districts, but also from all corners of Japan nationwide and overseas. It also hosts large numbers of medical professionals, researchers, and others on a constant basis. Notably, in cases where patients must undergo regular outpatient treatments for a certain period of time, such as radiotherapy or chemotherapy, regularly traveling to and from the hospital from home afar can impose a large physical burden on patients. For this reason, there was a need for a facility close to the hospital where these patients could stay overnight or for longer periods.
NCC and Mitsui Fudosan have decided to develop a hospital-linked accommodation facility on the premises of NCC Hospital East, in order to meet the needs of visitors and improve convenience. The facility plans around 140 guestrooms. Larger guestrooms housing patients with company, and thosefitted with kitchens, electric appliances and other amenities for medium- and long-term residents are planned. In coordination with NCC Hospital East, the facility plans to provide emergency responses and consultations, and put in place a framework to support those going through medical treatment as theywork. NCC and Mitsui Fudosan will also work closely together to offer other relative services to assist cancer patients and family members.
■ Create a new clinical model by harnessing 5G, IT and other technologies
In June 2019, NCC and Mitsui Fudosan concluded a basic agreement for cooperation and collaboration on development of next-generation medical technologies and healthcare services. Under this agreement, NCC and Mitsui Fudosan have been working to establish a life science center to conquer and cure cancer. With plans to deploy new communications infrastructure such as 5G, the facility will be used as a testing ground for sensing devices and other technologies that assist with the health management of guests, with the goal of enabling telemedicine and home healthcare. Through these and other initiatives, NCC and Mitsui Fudosan will seek to create a new clinical model.
■ Create “A New Model for Hospitals and Neighborhoods” through the Kashiwa-no-ha Smart City
Located in Chiba Prefecture’s Kashiwa-no-ha area, which is home to the NCC Hospital East, the Kashiwa-no-ha Smart City seeks to develop a community solving problems of the future based on compatibility with preserving the environment, health and longevity, and the creation of new industries. NCC Hospital East has been conducting innovative research utilizing IT and other technologies, with the aim of developing new cancer treatments and clinical approaches. In order to promote open innovation in the form of private-public-academia partnership, Mitsui Fudosan has conducted initiatives such as Innovation Field Kashiwa-no-ha to accelerate demonstration projects with private companies, and Kashiwa-no-ha IoT Business Co-creation Lab, which seeks to drive widespread adoption and use of IoT and to create opportunities for IoT-related businesses. In 2019, Mitsui Fudosan, Kashiwa City, and other partners initiated the Kashiwa-no-ha Smart City Consortium. The consortium is working to build a data platform that links data from the private and public sectors and to create new applications and services based on the analysis and use of this data. NCC Hospital East is also engaged in coordination and collaboration on these initiatives as one of the consortium’s participants.
- June 24, 2019: “Conclusion of a Basic Agreement for Cooperation and Collaboration on Development of Next-Generation Medical Technologies and Healthcare Services in the Kashiwa-no-ha Area”
- June 20, 2019: “Kashiwanoha IoT Business Co-creation Lab Starts Trial Tests for Healthcare Project Using IoT Technology to Automatically Visualize Patient Movement Flow and Improve Waiting Times”
- June 5, 2019: “Selected by the Ministry of Land, Infrastructure, Transport and Tourism as a model project for a smart city towards realizing “Society 5.0,” Kashiwa-no-ha Smart City will evolve into a smart, compact city driven by data”
Remarks by Atsushi Ohtsu, M.D., Ph.D., Director, National Cancer Center Hospital East
“NCC Hospital East is pushing ahead with hospital-wide initiatives, with the objectives of providing the best cancer treatment in the world and generating new cancer treatments. The construction of this accommodation facility in partnership with Mitsui Fudosan will allow us to more easily accommodate the increasing numbers of patients and their family members from distant areas of Japan and overseas. Moreover, we intend to form an innovative next-generation medical partnership with the accommodation facility by, for example, deploying cutting-edge ICT and AI.”
Remarks by Yoshikazu Kitahara, Managing Director and Executive Vice President, Mitsui Fudosan
“Mitsui Fudosan is building the world’s most cutting-edge smart city in the Kashiwa-no-ha area. The themes for neighborhood creation are environmental harmony, health and longevity, and the creation of new industries. Mitsui Fudosan is greatly honored to have been selected by NCC Hospital East to carry out this hotel business. We plan to make this an unprecedented project based on collaboration between a hospital and hotel through such means as applying cutting-edge ICT to link patients staying at the hotel and NCC Hospital East. We would like to use this business as an opportunity to promote further collaboration with NCC Hospital East. By doing so, we intend to push ahead with our efforts to build a major life science center in Kashiwa-no-ha, as we seek to create a platform for driving technological innovation that leads to greater human happiness.”
■National Cancer Center Hospital East (https://www.ncc.go.jp/en/ncce/index.html)
The National Cancer Center Hospital East (NCC Hospital East) was established in 1992 with the objectives of providing the best cancer treatment in the world and generating new cancer treatments. It is a leading specialized cancer hospital in Japan, treating over 9,000 new patients each year. NCC Hospital East has been selected by the national government as a core hospital for clinical research, a core hospital for genomic treatment, and a center for development and collaboration on next-generation medical devices. Together with its adjoining facility, the Exploratory Oncology Research & Clinical Trial Center (NCC-EPOC), NCC Hospital East has produced many achievements as a TR research and development center based on cross-organizational networks. In this role, NCC Hospital East has been promoting the development of innovative cancer medicines and medical devices, including first-in-human trials of new cancer medicines and investigator-initiated trials.
■Mitsui Fudosan [Website] Kashiwa-no-ha Smart City (https://www.kashiwanoha-smartcity.com/en/)
Mitsui Fudosan is a comprehensive developer that creates new value by striving to resolve social issues through urban development. At Kashiwa-no-ha Smart City, Mitsui Fudosan aims to create a smart, compact city driven by data through the introduction of new technologies such as AI and IoT. It has been selected by the Ministry of Land, Infrastructure, Transport and Tourism as an advanced model project for a smart city towards realizing “Society 5.0.” Going forward, Mitsui Fudosan will work on developing smart medical institution services for health and medicine. In addition, the Mitsui Fudosan Group believes that it can contribute significantly to the realization of Society 5.0, which is advocated by the Japanese government, and to the achievement of the SDGs, by promoting ESG management, which means advancing businesses based on an awareness of the Environment (E), Society (S), and Governance (G).
Planned construction site
|6-5-1, Kashiwa-no-ha, Kashiwa City, Chiba Prefecture
|Approximately six minutes by bus from the west exit of Kashiwanoha-campus Station, on the Tsukuba Express Line
|Approx. 3,950 m2 (approx. 42,517 ft2)
|Around December 2020 (scheduled)
|Around summer 2022 (scheduled)